Capital will fund Castle Creek’s D-Fi Phase 3 clinical trial for patients with dystrophic epidermolysis bullosa through ...

Global Premiere Set for Rare Disease Day, Feb. 28, 2025ASHBURN, Va., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals ...

Pharmaceuticals has closed a royalty financing agreement with Castle Creek Biosciences to support the Phase 3 clinical study of ...

Quoin Pharmaceuticals (QNRX) announced the launch of the first episode in its “Living with Netherton” video series dedicated to giving voice to ...

The details of this year’s ceremony in Glasgow, hosted by Elaine C Smith and Sanjeev Kohli, will be confirmed in the David ...